IFG Advisory’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,264
Closed -$223K 401
2020
Q1
$223K Sell
1,264
-143
-10% -$26.9K 0.05% 324
2019
Q4
$269K Hold
1,407
0.05% 334
2019
Q3
$236K Sell
1,407
-2,520
-64% -$411K 0.05% 353
2019
Q2
$657K Sell
3,927
-42
-1% -$5.82K 0.12% 176
2019
Q1
$581K Buy
3,969
+1,158
+41% +$168K 0.11% 179
2018
Q4
$375K Sell
2,811
-8
-0.3% -$1.31K 0.09% 216
2018
Q3
$536K Sell
2,819
-221
-7% -$40.6K 0.1% 195
2018
Q2
$506K Sell
3,040
-45
-1% -$7.22K 0.1% 188
2018
Q1
$519K Buy
3,085
+546
+22% +$91.6K 0.12% 180
2017
Q4
$432K Buy
+2,539
New +$456K 0.1% 197

Other funds holding AGN

IFG Advisory's AGN Position: Q2 2020 in Review

IFG Advisory sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,264 shares — an estimated $223K sold.

IFG Advisory first reported a position in AGN in Q4 2017 and held it in 10 quarters. The position peaked at $657K in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • IFG Advisory reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • IFG Advisory sold 1,264 Allergan plc shares in Q2 2020, an estimated $223K.
  • IFG Advisory first reported a position in Allergan plc in Q4 2017 and held it in 10 quarters.
  • IFG Advisory's Allergan plc position peaked at $657K in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on IFG Advisory's 13F filing for Q2 2020, filed 10 Aug 2020.